Related Experiment Video
Updated: Jul 22, 2026
09:28
One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
Published on: June 25, 2010
Oat products and lipid lowering. A meta-analysis
C M Ripsin1, J M Keenan, D R Jacobs
1Department of Family Practice and Community Health, University of Minnesota, Minneapolis 55414.
JAMA
|July 4, 1992
Summary
Consuming oats modestly lowers blood total cholesterol. This effect is more pronounced in individuals with higher initial cholesterol levels and when consuming at least 3g of soluble fiber daily.
Area of Science:
- Nutrition Science
- Cardiovascular Health
- Dietary Interventions
Background:
- Elevated blood total cholesterol is a significant risk factor for cardiovascular disease.
- Dietary modifications are a cornerstone of cholesterol management.
- Oats are recognized for their potential health benefits, including cholesterol-lowering properties.
Purpose of the Study:
- To evaluate the effect of oat consumption on blood total cholesterol levels.
- To identify factors that may modify the relationship between oat intake and cholesterol reduction.
Main Methods:
- A systematic review and meta-analysis of published and unpublished randomized controlled trials.
- Inclusion criteria required formal assessment of diet and body weight changes.
- Data synthesis used the DerSimonian and Laird method for calculating summary effect sizes.
Main Results:
- Oat consumption resulted in a modest reduction in blood total cholesterol.
- The overall effect size for cholesterol reduction was -0.13 mmol/L.
- Greater cholesterol reductions were observed in participants with higher baseline cholesterol levels (≥ 5.9 mmol/L) and those consuming ≥ 3g of soluble fiber.
Conclusions:
- Incorporating oat products into the diet supports a modest reduction in blood cholesterol.
- The cholesterol-lowering effect of oats is influenced by baseline cholesterol levels and soluble fiber intake.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...